We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+9.61%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$21.6B
AUM Growth
+$2.85B
Cap. Flow
+$1.11B
Cap. Flow %
5.1%
Top 10 Hldgs %
30.93%
Holding
1,357
New
41
Increased
770
Reduced
236
Closed
79

Top Buys

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$203M
2
NOW icon
ServiceNow
NOW
+$181M
3
PSA icon
Public Storage
PSA
+$132M
4
ELS icon
Equity Lifestyle Properties
ELS
+$129M
5
OHI icon
Omega Healthcare
OHI
+$114M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$188M
2
SNOW icon
Snowflake
SNOW
+$152M
3
IRM icon
Iron Mountain
IRM
+$149M
4
PLD icon
Prologis
PLD
+$131M
5
AMT icon
American Tower
AMT
+$100M

Sector Composition

Rank Sector Weight
1 Real Estate 41.83%
2 Technology 20.16%
3 Communication Services 6.63%
4 Financials 5.64%
5 Consumer Discretionary 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APLS
1101
DELISTED
Apellis Pharmaceuticals
APLS
$13K ﹤0.01%
447
– –
DYN icon
1102
Dyne Therapeutics
DYN
$4.25B
$13K ﹤0.01%
371
– –
MRUS
1103
DELISTED
Merus
MRUS
$13K ﹤0.01%
251
– –
FOLD
1104
DELISTED
Amicus Therapeutics
FOLD
$12K ﹤0.01%
1,130
– –
KYMR icon
1105
Kymera Therapeutics
KYMR
$8.63B
$12K ﹤0.01%
245
+35
+17% +$1.55K
MASS icon
1106
908 Devices
MASS
$316M
$12K ﹤0.01%
3,372
-338
-9% -$1.5K
RYTM icon
1107
Rhythm Pharmaceuticals
RYTM
$7.34B
$12K ﹤0.01%
227
– –
BMO icon
1108
Bank of Montreal
BMO
$124B
$11K ﹤0.01%
120
– –
GH icon
1109
Guardant Health
GH
$18.8B
$11K ﹤0.01%
468
+56
+14% +$1.58K
PTCT icon
1110
PTC Therapeutics
PTCT
$6.21B
$11K ﹤0.01%
289
– –
XENE icon
1111
Xenon Pharmaceuticals
XENE
$6.21B
$11K ﹤0.01%
288
+36
+14% +$1.45K
ACAD icon
1112
Acadia Pharmaceuticals
ACAD
$4.43B
$10K ﹤0.01%
641
+90
+16% +$1.5K
APGE icon
1113
Apogee Therapeutics
APGE
$10.1B
$10K ﹤0.01%
171
+34
+25% +$1.63K
GERN icon
1114
Geron
GERN
$905M
$10K ﹤0.01%
2,247
– –
GPCR icon
1115
Structure Therapeutics
GPCR
$3.38B
$10K ﹤0.01%
226
+73
+48% +$2.82K
IBRX icon
1116
ImmunityBio
IBRX
$7.21B
$10K ﹤0.01%
2,620
– –
PTGX icon
1117
Protagonist Therapeutics
PTGX
$8.72B
$10K ﹤0.01%
215
– –
AGIO icon
1118
Agios Pharmaceuticals
AGIO
$2.09B
$9K ﹤0.01%
204
– –
AMPH icon
1119
Amphastar Pharmaceuticals
AMPH
$895M
$9K ﹤0.01%
185
+31
+20% +$1.36K
EWTX icon
1120
Edgewise Therapeutics
EWTX
$4.3B
$9K ﹤0.01%
344
– –
MYGN icon
1121
Myriad Genetics
MYGN
$485M
$9K ﹤0.01%
326
– –
SWTX
1122
DELISTED
SpringWorks Therapeutics
SWTX
$9K ﹤0.01%
291
+40
+16% +$1.49K
TWST icon
1123
Twist Bioscience
TWST
$5.31B
$9K ﹤0.01%
210
– –
SILA
1124
DELISTED
Sila Realty Trust
SILA
$9K ﹤0.01%
+362
New +$8.51K
AKRO
1125
DELISTED
Akero Therapeutics
AKRO
$8K ﹤0.01%
262
– –
43 44
45
46 47

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2024 Portfolio in Review

As of Q3 2024, Daiwa Securities Group held 1,357 positions worth $21.6B, up 15% from $18.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Daiwa Securities Group deployed $1.11B of net new capital in Q3 2024, opening 41 new positions and adding to 770 existing holdings. Its largest new stake was Lineage Inc: 465,245 shares worth $36.5M.

By sector, the portfolio is most concentrated in Real Estate at 42% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Tesla, an estimated $188M trimmed.

  • Daiwa Securities Group's largest Q3 2024 buy was Lineage Inc: 465,245 shares worth $36.5M.
  • Daiwa Securities Group added most to CrowdStrike in Q3 2024, an estimated $203M increase.
  • Daiwa Securities Group's biggest Q3 2024 reduction was Tesla, cutting an estimated $188M.
  • Daiwa Securities Group fully exited Lam Research in Q3 2024, selling an estimated $26.6M.
  • Daiwa Securities Group's ten largest holdings make up 31% of its $21.6B portfolio in Q3 2024.
  • Daiwa Securities Group opened 41 new positions and closed 79 in Q3 2024.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $21.6B.

Based on Daiwa Securities Group's 13F filing for Q3 2024, filed 12 Nov 2024.